Veeva Vault CTMS Validation & Compliance

Yes. A CTMS used to manage and provide oversight of GCP clinical trials is a GxP-regulated computerized system, so it must be validated for its intended use and kept in a validated state. Validation demonstrates the system reliably performs its functions and that electronic records and signatures meet 21 CFR Part 11 and, in the EU, EU Annex 11. The data governance and computerized-systems expectations in ICH E6(R3) make this especially important for clinical systems. IntuitionLabs delivers the customer side of that validation using a risk-based GAMP 5 approach.

Veeva validates and continuously regression-tests the platform and supplies a validation package with each release; the regulated company validates its configuration, data migration, integrations, and intended use. Regulators hold the sponsor or CRO accountable for the system as used — not the vendor. We deliver your side of that line, leveraging Veeva's evidence so you never re-test what has already been verified, while focusing effort where your risk actually lives. This mirrors the supplier-leverage approach described in ISPE GAMP 5 Second Edition and the FDA's general principles of software validation.

Vault CTMS is a configured commercial product, so under GAMP 5 it is generally treated as a Category 4 system — validation focuses on your specific configuration (study and site object models, lifecycles, study roles, workflows) rather than the underlying platform code. Any custom extensions, scripts, or bespoke integrations move into Category 5 and warrant deeper scrutiny. The GAMP 5 Second Edition guide is explicit that effort should be proportionate to risk and patient impact, supported by the quality risk management principles in ICH Q9(R1). We categorize each component and scope testing accordingly.

We build a clause-by-clause compliance matrix linking each 21 CFR Part 11 requirement — audit trails, electronic signatures, access controls, record retention, copies of records — to a specific Vault control and a piece of test evidence. Vault provides native capabilities for audit trails, signature manifestations, and granular security that map cleanly onto Part 11, but the configuration must be verified as implemented for your intended use. The same matrix is extended to EU Annex 11 for European operations, giving you a single defensible position across markets.

The revised ICH E6(R3) guideline — adopted by the FDA in September 2025 and phased in by the EMA from mid-2025 — places strong emphasis on data governance, computerized-system reliability, and quality-by-design across the trial lifecycle. A validated CTMS is part of demonstrating that the systems used to manage and oversee a trial are fit for purpose and that their data is attributable, traceable, and secure. Our validation artifacts are designed to support both a Part 11 inspection and a GCP inspection, so the same evidence base answers questions from ICH E6(R3) reviewers and computer-system auditors alike.

When you move from a legacy CTMS — Oracle Siebel, a Clario/BioClinica system, or spreadsheets — you must prove the migrated records are complete, accurate, and correctly related. We reconcile by count, by content, and by relationship (study-to-site-to-visit-to-issue), document exception handling, and verify that audit-trail history and key dates survive the move. This protects data integrity in line with the MHRA GxP data integrity guidance and ALCOA+ principles. Migration is typically the highest-risk part of a CTMS program, so it receives focused, documented validation rather than a cursory sign-off.

Each integration is qualified as part of the validated system. For the Vault EDC–CTMS connection and for connections to eTMF, safety, and ERP for site payments, we verify that data transfers correctly, that audit trails and data integrity are preserved across the system boundary, and that failure and reconciliation handling work as designed. The configuration steps are documented in Veeva's Clinical Operations-EDC Connection help, and for non-Veeva systems we qualify the custom API integration with the same rigor. Integration qualification protocols and reports become part of your traceability matrix.

Veeva delivers multiple general releases each year, so a one-time validation is not enough. We implement a continuous-release management process: a risk-based impact assessment for each release, targeted regression testing of the functions and integrations you actually use, and documentation that keeps the validated state current without a full revalidation every quarter. This periodic, risk-proportionate approach is consistent with GAMP 5 and keeps your evidence inspection-ready year-round rather than drifting out of date after go-live.

A typical Vault CTMS validation engagement produces a coherent, traceable evidence set: a validation plan, user requirements specification, risk assessment, IQ/OQ/PQ protocols and reports, a requirements-to-test traceability matrix, migration and integration qualification reports, a Part 11/Annex 11 compliance matrix, and the periodic-review and change-control SOPs that maintain the validated state. Everything is scaled to your risk profile and mapped to the regulations your markets require, following the structure in the FDA's general principles of software validation. The result is a binder an inspector can actually follow, not documentation for its own sake.

Yes. We provide periodic review execution, audit-trail review, mock inspections, and ready-to-present evidence packs so your validated state can be demonstrated to an FDA, EMA, or MHRA inspector at any time. Because clinical operations systems are squarely in scope for GCP inspections, we prepare for the questions inspectors actually ask — traceability, audit trails, change-control records, and migration reconciliation first. Professional bodies such as the Association of Clinical Research Professionals and the Drug Information Association publish useful context on inspection expectations. Our managed services team can also maintain this readiness on an ongoing basis — see managed services.